The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
Hello A warm welcome on this Ichimoku analysis on DIVIS LAB Currently stock in a no fresh trade zone. Key levels to watch either below 4400 or above 4525
0.786 can be seen as a previous point of resistance now that price has moved higher than this level, it will be seen as a point of support for the breakdown of the rising wedge , a pattern that is commonly bearish (as you can see on the chart) Pharmaceutical companies are possibly hot right now, due to the emergence of the new COVID variant. Buy the Dip.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 4:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
Will it break the triangle pattern formed from Dec 2019? Not easy to tell but I'm thinking of a bullish breakout. Time will tell.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below support zone & the lower trendline. The target is placed near swing high.
Hello and a warm welcome to this technical outlook on Dr Reddy based on Harmonic Patterns. In daily time frame it has made a Bullish Harmonic Cypher suggesting an up move possible till 4800/5000 with a stop loss at 4500.
Looks like a push to the 618 fib retracement might be up next. If we have an impulsive 5 up incoming the chart should look like this IMO.
The stock has broken out with good volumes and retested, so it may undergo a rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 3:1 SL is placed below support zone & the previously upper & lower trendline. The target is placed based on fundamentals.
Nifty Pharma index of it breaks n sustain above 14560 then one can buy pharma majors. All frontline pharma stocks can b bought above this . Cipla, sunpharma, lupin, auropharma, biocon & glenmark.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 2:1 SL is placed below support zone & the lower trendline. The target is placed based on fundamentals and near all time high.
Beyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
Hi there. Price is forming a big reversal pattern to change its direction. Also is close to 0 value which is a very good sign. Watch strong price action at the current levels for buy.
1. rising wedge pattern formation 2. and inverted flag pattern 3. a clear short opportunity
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891 Entry on the bullish break of the dynamic...
NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily. Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug. High risk with potentially high reward: up to a 25% drawdown and a...
A company with over 10 years of consistent and constant growth, a wide coverage of products already on the market and... despite an excellent quarterly for a news or a trail .. boom .. It drops suddenly ? In my opinion this is sheer market madness, the sites I use as a reference for fundamental analysis confirm to me what I say, the company always be more than...